For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260219:nRSS6987Ta&default-theme=true
RNS Number : 6987T Imaging Biometrics Limited 19 February 2026
Imaging Biometrics Limited
("IBAI" or the "Company")
Board Appointment
Imaging Biometrics Limited (LSE: IBAI) is pleased to announce the appointment
of John Charles Richardson as a Non-Executive Director with effect from 1
March 2026 and will become a member of the remuneration and audit committees.
John is a British Chartered Engineer with over 40 years of experience in
technology, operations and strategic management. A graduate of the University
of Manchester in Electrical and Electronic Engineering, he spent nearly three
decades in engineering management at a major international engineering
company, progressing to senior roles spanning corporate engineering strategy,
marketing and information security.
Since then, he has held a series of executive and board-level roles across
listed and private technology companies in sectors including machine
monitoring, life sciences and land surveying. He has a strong record of
operational delivery, having achieved ISO 9001 and CE certifications,
established international distribution networks across China, the USA and
South Korea, and driven significant revenue growth.
Current Directorships Previous
Directorships in the past five years
ChampagneWebs Limited Nanosynth Group plc
Gyrometric Systems Limited Geocurve Ltd
John currently does not hold any Ordinary Shares in the Company.
There are no additional matters that would require disclosure under LR 6.4.8R
in respect of the appointment of John Richardson.
--ENDS-
For further information, please contact:
Imaging Biometrics Limited
Trevor Brown/Brett Skelly/Michael Schmainda
Tel: 020 7469 0930
AlbR Capital Limited (Broker)
Lucy Williams
Tel: 020 7220 9797
About Imaging Biometrics Limited: Imaging Biometrics Limited (LON: IBAI) is
the parent company of Imaging Biometrics LLC and Kirkstall Ltd, focused on
advancing innovative solutions that support improved decision‑making and
outcomes across healthcare and life sciences, spanning quantitative medical
imaging and advanced in vitro modelling technologies. Through its
subsidiaries, the company delivers products, services, and expertise that help
clinicians, researchers, and industry partners work more efficiently and
effectively.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABGGDDLSBDGLC
Copyright 2019 Regulatory News Service, all rights reserved